Megha M Tollefson1, Ilona J Frieden. 1. Departments of Dermatology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. tollefson.megha@mayo.edu
Abstract
BACKGROUND AND OBJECTIVES: Infantile hemangiomas (IH) are recognized as growing rapidly during the first months of life, but details of early growth before 3 months of age have not been well-characterized. Our goal was to study early IH growth by using parental photographs of infant children with facial IHs to better understand early hemangioma growth, with the aim of improving guidance for physicians and parents of infants with high-risk IH. METHODS: Serial images of 30 infants showing IH at intervals of 1 to 2 weeks up to 6 months were analyzed for characteristics of color, thickness, and distortion of anatomic landmarks. The presence or absence of an IH precursor at birth was noted. Mean scores per age interval were compiled. Results were analyzed by using signed rank test. An assessment of "optimal time for referral" was made. RESULTS: IH growth was nonlinear; most rapid growth occurred between 5.5 and 7.5 weeks of age. The mean "optimal age for referral" was 4 weeks of age. Hemangioma precursors were present at birth in 65% of patients. CONCLUSIONS: The most rapid hemangioma growth occurs before 8 weeks of age, much earlier than previously appreciated. Specialty evaluation and initiation of treatment, however, typically occur after the age of most rapid growth. Our findings suggest a need for a paradigm shift in the timing of referral and initiation of treatment of high-risk IH so that therapy can be initiated before or early in the course of most rapid growth, rather than after it is already completed.
BACKGROUND AND OBJECTIVES:Infantile hemangiomas (IH) are recognized as growing rapidly during the first months of life, but details of early growth before 3 months of age have not been well-characterized. Our goal was to study early IH growth by using parental photographs of infantchildren with facial IHs to better understand early hemangioma growth, with the aim of improving guidance for physicians and parents of infants with high-risk IH. METHODS: Serial images of 30 infants showing IH at intervals of 1 to 2 weeks up to 6 months were analyzed for characteristics of color, thickness, and distortion of anatomic landmarks. The presence or absence of an IH precursor at birth was noted. Mean scores per age interval were compiled. Results were analyzed by using signed rank test. An assessment of "optimal time for referral" was made. RESULTS: IH growth was nonlinear; most rapid growth occurred between 5.5 and 7.5 weeks of age. The mean "optimal age for referral" was 4 weeks of age. Hemangioma precursors were present at birth in 65% of patients. CONCLUSIONS: The most rapid hemangioma growth occurs before 8 weeks of age, much earlier than previously appreciated. Specialty evaluation and initiation of treatment, however, typically occur after the age of most rapid growth. Our findings suggest a need for a paradigm shift in the timing of referral and initiation of treatment of high-risk IH so that therapy can be initiated before or early in the course of most rapid growth, rather than after it is already completed.
Authors: Daniel M O'Connor; Olivia S Jew; Marissa J Perman; Leslie A Castelo-Soccio; Flaura K Winston; Patrick J McMahon Journal: JAMA Dermatol Date: 2017-12-01 Impact factor: 10.282
Authors: Andrew H Y Lee; Krista L Hardy; David Goltsman; Peter Liou; Maria C Garzon; Christine H Rohde; June K Wu Journal: J Plast Reconstr Aesthet Surg Date: 2014-05-16 Impact factor: 2.740
Authors: Peter H Hoeger; John I Harper; Eulalia Baselga; Damien Bonnet; Laurence M Boon; Marta Ciofi Degli Atti; Maya El Hachem; Arnold P Oranje; Agneta Troilius Rubin; Lisa Weibel; Christine Léauté-Labrèze Journal: Eur J Pediatr Date: 2015-05-29 Impact factor: 3.183
Authors: Christopher J Fong; Maria C Garzon; Jennifer W Hoi; Hyun K Kim; Christine T Lauren; Kimberly Morel; Lauren Geller; Nina Antonov; Nicole Weitz; June Wu; Andreas H Hielscher Journal: Pediatr Dermatol Date: 2017-05-26 Impact factor: 1.588
Authors: Sarah L Chamlin; Anthony J Mancini; Jin-Shei Lai; Jennifer L Beaumont; David Cella; Denise Adams; Beth Drolet; Eulalia Baselga; Ilona J Frieden; Maria Garzon; Kristin Holland; Kimberly A Horii; Anne W Lucky; Catherine McCuaig; Denise Metry; Kimberly D Morel; Brandon D Newell; Amy J Nopper; Julie Powell; Dawn Siegel; Anita N Haggstrom Journal: J Invest Dermatol Date: 2015-01-23 Impact factor: 8.551
Authors: Katelyn R Anderson; Jennifer J Schoch; Christine M Lohse; Jennifer L Hand; Dawn M Davis; Megha M Tollefson Journal: J Am Acad Dermatol Date: 2015-10-19 Impact factor: 11.527
Authors: Shoná A Burkes; Manish Patel; Denise M Adams; Adrienne M Hammill; Kenneth P Eaton; R Randall Wickett; Marty O Visscher Journal: Int J Dermatol Date: 2016-04-08 Impact factor: 2.736